-
「同位素标记抑制剂」CAS:201612-55-7|2-Deoxy-D-glucose-13C
作者:德尔塔生物 日期:2025-06-13
生物活性:2-Deoxy-D-glucose-13C is the 13C labeled 2-Deoxy-D-glucose. 2-Deoxy-D-glucose is a glucose analog that acts as a competitive inhibitor of glucose metabolism, inhibiting glycolysis via its actions on hexokinase[1][2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.2-Deoxy-D-glucose-13C 相关抗体:ERK1/2 AntibodyE-Cadherin Antibody (YA470)Fatty Acid Synthase Antibody (YA766)DYKDDDDK Tag (FLAG) AntibodyGAPDH AntibodyGFP Antibodyp53 Antibody (YA250)RUNX2 AntibodyFerritin Heavy Chain AntibodyCOX2 AntibodyCtip2 AntibodyCyclin D1 Antibody (YA485)Cytochrome C Antibodyc-Myc AntibodyCyclin E1 AntibodyAIF Antibody (YA636)ALIX AntibodyCNPase AntibodyCortactin AntibodyCOX IV AntibodyCOX2/Cyclooxygenase 2 AntibodyCyclin A2 AntibodyCyclin B1 Antibody (YA486)DR5 AntibodyDrosha AntibodyE-Cadherin Antibody (YA778)EEA1 AntibodyEpCAM Antibody (YA772)Fatty Acid Synthase AntibodyFIP200 Antibody分子量:165.15Formula:C513CH12O5CAS 号:201612-55-7非标记 CAS:154-17-6性状:固体颜色:White to off-white中文名称:2-脱氧-D-葡萄糖 13C运输条件:Room temperature in continental US; may vary elsewhere.储存方式:4°C, sealed storage, away from moisture*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
-
「同位素标记抑制剂」CAS:2468771-43-7|Apatinib-d8 free base
作者:德尔塔生物 日期:2025-06-13
生物活性:Apatinib-d8 (free base) is the deuterium labeled Apatinib free base[1]. Apatinib free base (YN968D1 free base) is an orally bioavailable tyrosine kinase inhibitor, which selectively targets VEGFR-2 (IC50=1 nM). Apatinib free base (YN968D1 free base) is an anti-angiogenic drug for the research of advanced or metastatic gastric cancer. Apatinib free base (YN968D1 free base) potently inhibits Ret, c-Kit and c-Src with IC50s of 13, 429 and 530 nM, respectively. It also inhibits cellular phosphorylation of VEGFR-2, c-kit and PDGFRβ[2][3][4].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Apatinib-d8 free base 相关抗体:c-Kit Antibody (YA502)Src AntibodySRC1 AntibodyVEGF Receptor 2 Antibody (YA014)Phospho-Src (Tyr419) AntibodyFYN AntibodyLck Antibody (YA712)Lyn Antibody (YA707)VEGF Receptor 1 AntibodyVEGFA AntibodyVEGF Receptor2 Antibody PLGF Antibody (YA1812)VEGFD Antibody (YA2385)CSK Antibody (YA2742)c-Kit AntibodySCF AntibodyFYB Antibody (YA973)FYB Antibody (YA974)TAGLN/Transgelin Antibody (YA1206)PGF Antibody (YA1434)Neuropilin 1 Antibody (YA1831)Yes1 Antibody (YA1897)SHC Antibody (YA2394)VEGFB Antibody (YA2627)Phospho-Src (Tyr530) Antibody (YA2656)PELP1 Antibody (YA2962)Tyrosine Protein Kinase HCK
-
「同位素标记抑制剂」CAS:1093851-61-6|Oseltamivir-d3
作者:德尔塔生物 日期:2025-06-13
生物活性:Oseltamivir-d3 is a deuterium labeled Oseltamivir. Oseltamivir is an influenza virus neuraminidase inhibitor (NAI). Oseltamivir inhibits influenza A/H3N2, A/H1N2, A/H1N1, and B viruses with mean IC50s of 0.67, 0.9, 1.34 and 13 nM, respectively. Anti-influenza A and B agent[1].分子量:315.42Formula:C16H25D3N2O4CAS 号:1093851-61-6非标记 CAS:196618-13-0性状:固体颜色:White to off-white中文名称:奥司他韦-d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:1246820-62-1|Losartan-d4 (carboxylic acid)
作者:德尔塔生物 日期:2025-06-13
生物活性:Losartan-d4 (carboxylic acid) is the deuterium labeled Losartan (EXP-3174), which is an angiotensin II receptor antagonist.分子量:440.92Formula:C22H17D4ClN6O2CAS 号:1246820-62-1非标记 CAS:124750-92-1性状:固体颜色:Off-white to light yellow中文名称:氯沙坦羧酸 d4运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:851073-55-7|Lignoceric acid-d3
作者:德尔塔生物 日期:2025-06-13
生物活性:Lignoceric acid-d3 is the deuterium labeled Lignoceric acid[1]. Lignoceric acid (Tetracosanoic acid) is a 24-carbon saturated (24:0) fatty acid, which is synthesized in the developing brain. Lignoceric acid is also a by-product of lignin production. Lignoceric acid can be used for Zellweger cerebro‐hepato‐renal syndrome and adrenoleukodystrophy research[2][3].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Lignoceric acid-d3 相关抗体:BNSP AntibodyFACL4 AntibodyBrdU Antibody (YA578)GAPDH AntibodyGlucose 6 Phosphate Dehydrogenase AntibodyMETTL3 AntibodyTSG101 AntibodyAlkaline Phosphatase AntibodyCalnexin Antibody (YA573)Lamin A/C AntibodyLamin B1 AntibodyLAMP1 AntibodyLAMP2 Antibody (YA713)LAMP2a AntibodyNQO1 Antibody (YA697)NQO1 Antibody (YA261)OPA1 AntibodyRBM3 AntibodySynaptophysin Antibody (YA043)Laminin beta 1 AntibodyHeme Oxygenase 1 AntibodyKi67 Antibody (YA717)Ki67 Antibody (YA322)Asparagine Synthetase AntibodyCalnexin AntibodyKi67 Antibody (YA001)Osteopontin AntibodySynaptophysin Antibody (YA664)TREM2 AntibodyGAPDH Antibody (YA848)分子量:371.66Formula:C24H45D3O2CAS 号:851073-55-7非标记 CAS:557-59-5性状:固体颜色:White to off-white中文名称:二十四烷酸-d3; 木焦油酸-d3; 木蜡酸-d3运输
-
「同位素标记抑制剂」CAS:203645-63-0|Amitriptyline-d6 hydrochloride
作者:德尔塔生物 日期:2025-06-13
生物活性:Amitriptyline-d6 (hydrochloride) is the deuterium labeled Amitriptyline hydrochloride. Amitriptyline hydrochloride is an inhibitor of serotonin reuptake transporter (SERT) and noradrenaline reuptake transporter (NET), with Kis of 3.45 nM and 13.3 nM for human SERT and NET, respectively. Amitriptyline hydrochloride also weakly binds to dopamine reuptake transporter (DAT) with a Ki of 2.58 μM. Amitriptyline hydrochloride also inhibits adrenergic, muscarinic, histamine and 5-HT receptors. Amitriptyline hydrochloride is a TrkA and TrkB receptors agonist with potent neurotrophic activity. Amitriptyline hydrochloride has antidepressant activity[1][2][3].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Amitriptyline-d6 hydrochloride 相关抗体:TrkA AntibodyADGRE1 (F4/80) Antibody (YA002)xCT Antibody (YA006)TrkB AntibodyxCT Antibody (YA652)BDNF AntibodyPhospho-TrkA/B (Tyr490/Tyr516) AntibodyTrk B AntibodyADGRE1 (F4/80) Antibody (YA920)ADRB2 AntibodyMTNR1A AntibodyNGF AntibodyAlpha-ENaC Antibodyp75 NGF Receptor Antibody (YA1245)Serotonin Transporter Antibody (YA1638)HTR7 Antibody (YA2796)HTR2C Antibody (YA3364)CRMP2 Antibody (YA3370)TrkA+B+C AntibodySalbutamol Antibody (YA901)Clenbuterol Antibody (YA904)Mus
-
「同位素标记抑制剂」CAS:159490-55-8|Ketoprofen-d3
作者:德尔塔生物 日期:2025-06-13
生物活性:Ketoprofen-d3 is the deuterium labeled Ketoprofen. Ketoprofen (RP-19583) is a non-steroidal antiinflammatory agent, acting as a potent inhibitor of COX, with IC50s of 2 nM and 26 nM for COX-1 and COX-2 in human blood monocytes, respectively[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Ketoprofen-d3 相关抗体:ERK1/2 AntibodyE-Cadherin Antibody (YA470)Fatty Acid Synthase Antibody (YA766)DYKDDDDK Tag (FLAG) AntibodyGAPDH AntibodyGFP Antibodyp53 Antibody (YA250)RUNX2 AntibodyFerritin Heavy Chain AntibodyCOX2 AntibodyCtip2 AntibodyCyclin D1 Antibody (YA485)Cytochrome C Antibodyc-Myc AntibodyCyclin E1 AntibodyAIF Antibody (YA636)ALIX AntibodyCNPase AntibodyCortactin AntibodyCOX IV AntibodyCOX2/Cyclooxygenase 2 AntibodyCyclin A2 AntibodyCyclin B1 Antibody (YA486)DR5 AntibodyDrosha AntibodyE-Cadherin Antibody (YA778)EEA1 AntibodyEpCAM Antibody (YA772)Fatty Acid Synthase AntibodyFIP200 Antibody分子量:257.30Formula:C16H11D3O3CAS 号:159490-55-8非标记 CAS:22071-15-4性状:固体颜色:White to off-white中文名称:酮洛芬 d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:4°C, sealed storage, away from moisture and light*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storag
-
「同位素标记抑制剂」CAS:1217620-38-6|Navitoclax-d8
作者:德尔塔生物 日期:2025-06-13
生物活性:Navitoclax-d8 is the deuterium labeled Navitoclax. Navitoclax (ABT-263) is a potent and orally active Bcl-2 family protein inhibitor that binds to multiple anti-apoptotic Bcl-2 family proteins, such as Bcl-xL, Bcl-2 and Bcl-w, with a Ki of less than 1 nM[1].体外研究(In Vitro):氢、碳和其他元素的稳定重同位素已被掺入药物分子中,主要用作药物开发过程中定量的示踪剂。氘代因其可能影响药物的药代动力学和代谢特征而受到关注[1]。德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Navitoclax-d8 相关抗体:Bcl-2 AntibodyBcl2 AntibodyBax Antibody (YA591)Bad AntibodyBak Antibody (YA592)BAX Antibody (YA825)Bcl-XL AntibodyBim AntibodyBNIP3 AntibodyPUMA AntibodyMCL1 AntibodyBak AntibodyBax Antibody (YA826)Bcl2 Antibody (YA824)BNIP3L AntibodyBAG2 Antibody (YA1398)Phospho-PML Protein (Ser518) Antibody (YA2632)Bid AntibodyBAG1 Antibody (YA932)BAG1 Antibody (YA933)Bcl10 Antibody (YA1188)BAP31 Antibody (YA1320)BCL2L1 Antibody (YA1359)BAG3 Antibody (YA2240)Bok Antibody (YA2289)BPR Antibody (YA2393)DYNLL1 Antibody (YA2724)Bcl2 L14 Antibody (YA2740)Bcl2 A1 Antibody (YA2743)Phospho-Bad (Ser112) Antibody (YA3099)分子量:982.66Formula:C47H47D8ClF3N5O6S3CAS 号:1217620-38-6非标记 CAS:923564-51-6性状:固体颜色:White to off-white中文名称:生根粉263 d8运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:1189889-44-8|Telmisartan-d3
作者:德尔塔生物 日期:2025-06-13
生物活性:Telmisartan-d3 is the deuterium labeled Telmisartan. Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM[1][2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Telmisartan-d3 相关抗体:Natriuretic Peptides A Antibody (YA1381)Angiotensinogen Antibody (YA2097)Natriuretic Peptides B Antibody (YA999)Natriuretic Peptides B Antibody (YA1000)Natriuretic Peptides B Antibody (YA1001)AGTR2 Antibody (YA3090)Angiotensin II Type 1 Receptor Antibody (YA3358)分子量:517.64Formula:C33H27D3N4O2CAS 号:1189889-44-8非标记 CAS:144701-48-4性状:固体颜色:White to off-white中文名称:替米沙坦 d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:1246817-44-6|Dabigatran-d3
作者:德尔塔生物 日期:2025-06-13
生物活性:Dabigatran-d3 is the deuterium labeled Dabigatran. Dabigatran (BIBR 953), an oral anticoagulant, is a reversible, potent, competitive direct thrombin inhibitor (Ki=4.5 nM). Dabigatran (BIBR 953) also inhibits thrombin-induced platelet aggregation (IC50=10 nM)[1][2].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Dabigatran-d3 相关抗体:PAR2 Antibody (YA2455)Protein C Antibody (YA2461)Thrombomodulin Antibody (YA891)Thrombomodulin Antibody (YA892)F2 AntibodyPAR6 Antibody (YA1536)Prothrombin Antibody (YA1753)PAR4 Antibody (YA2603)Protein S Antibody (YA2919)分子量:474.53Formula:C25H22D3N7O3CAS 号:1246817-44-6非标记 CAS:211914-51-1性状:固体颜色:Off-white to light yellow中文名称:达比加群 d3运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:1802168-46-2|Cabozantinib-d6
作者:德尔塔生物 日期:2025-06-13
生物活性:Cabozantinib-d6 is the deuterium labeled Cabozantinib. Cabozantinib is a potent multiple receptor tyrosine kinases (RTKs) inhibitor that inhibits VEGFR2, c-Met, Kit, Axl and Flt3 with IC50s of 0.035, 1.3, 4.6, 7 and 11.3 nM, respectively[1][2][3].IC50 & Target:Axl体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Cabozantinib-d6 相关抗体:ERK1/2 AntibodyE-Cadherin Antibody (YA470)Fatty Acid Synthase Antibody (YA766)DYKDDDDK Tag (FLAG) AntibodyGAPDH AntibodyGFP Antibodyp53 Antibody (YA250)RUNX2 AntibodyFerritin Heavy Chain AntibodyCOX2 AntibodyCtip2 AntibodyCyclin D1 Antibody (YA485)Cytochrome C AntibodyMet (C-Met) Antibodyc-Myc AntibodyCyclin E1 AntibodyPhospho-c-Met (Tyr1349) AntibodyAIF Antibody (YA636)ALIX Antibodyc-Kit Antibody (YA502)CNPase AntibodyCortactin AntibodyCOX IV AntibodyCOX2/Cyclooxygenase 2 AntibodyCyclin A2 AntibodyCyclin B1 Antibody (YA486)DR5 AntibodyDrosha AntibodyE-Cadherin Antibody (YA778)EEA1 Antibody分子量:507.54Formula:C28H18D6FN3O5CAS 号:1802168-46-2非标记 CAS:849217-68-1性状:固体颜色:White to off-white中文名称:卡博替尼 d6运输条件:Room temperature in continental US; may vary elsewhere.储存方式:4°C, protect from light*In solvent : -80°C, 6 months; -20°C, 1 month (
-
「同位素标记抑制剂」CAS:1638281-44-3|Osimertinib-d6
作者:德尔塔生物 日期:2025-06-13
生物活性:Osimertinib-d6 is a deuterium labeled osimertinib. Osimertinib is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M. Osimertinib overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer[1].体外研究(In Vitro):Osimertinib (AZD9291) (0-10 μM;72 小时) 显著抑制细胞增殖,对 PC-9,H3255,PC-9ER,H1957 细胞的 IC50 分别为 41、26、41 和 31 nM[2]。 Osimertinib (0-10 μM;72 小时) 抑制细胞增殖 (携带 T790M 突变、外显子 19del+T790M 或 L858R+T790M 的 Ba/F3 细胞),IC50 分别为 6、7 和 74 nM[2]。 Osimertinib (0-10 μM;72 小时) 抑制携带 EGFR 外显子 20 插入突变的 Ba/F3 细胞 (A763_Y764insFQEA (FQEA)、Y764_V765insHH (HH) 的 IC50 范围为 16-701 nM)、A767_V769dupASV (ASV) 和 D770_N771insNPG (NPG) 细胞)[2]。Osimertinib 在两种致敏突变体EGFR 细胞系中均表现出高水平的表型效力 (PC-9 中平均 IC50= 8 nM) 和 T790M (H1975 和 PC-9VanR 中的平均 IC50 分别为 11 和 40 nM) 。Osimertinib 对野生型 EGFR 的活性要低得多 (Calu3 和 H2073 中的平均 IC50 分别为 650 和 461 nM)[1]。Osimertinib (0.1 μM;48 小时) 诱导 Ba/F3 细胞凋亡 (EGFR 外显子 19del+T790M、EGFR L858R+T790M 的凋亡率分别为 40.9% 和 90%)[2]。德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Osimertinib-d6 相关抗体:c-Fos AntibodyCaveolin-1 AntibodyPhospho-EGFR (Tyr1068) AntibodyPhospho-EGFR (Tyr1173) Antibodyc-Fos Antibody (YA506)EGF AntibodyEGFR AntibodyEGR1 AntibodyPhospholipase C gamma 1 AntibodyPhospho-EGFR (Tyr1068) Antibody (YA204)HER2 AntibodyEGFR Antibody (YA775)HER2 Antibody (YA771
-
「同位素标记抑制剂」CAS:1868135-06-1|Sofosbuvir-d6
作者:德尔塔生物 日期:2025-06-13
生物活性:Sofosbuvir-d6 is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity.分子量:535.49Formula:C22H23D6FN3O9PCAS 号:1868135-06-1非标记 CAS:1190307-88-0性状:固体颜色:White to off-white中文名称:索非布韦 d6运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:1189694-02-7|4’-Hydroxy Flurbiprofen-d3
作者:德尔塔生物 日期:2025-06-13
生物活性:4’-Hydroxy Flurbiprofen-d3 is the deuterium labeled 4’-Hydroxy Flurbiprofen[1].体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.分子量:263.28Formula:C15H10D3FO3CAS 号:1189694-02-7性状:固体颜色:White to off-white运输条件:Room temperature in continental US; may vary elsewhere.储存方式:Powder:-20°C:3 years,4°C:2 yearsIn solvent:-80°C:6 months,-20°C:1 month
-
「同位素标记抑制剂」CAS:1392826-25-3|Tetrabenazine-d6
作者:德尔塔生物 日期:2025-06-13
生物活性:Tetrabenazine-d6 (Deutetrabenazine) is a deuterium-labled Tetrabenazine (HY-B0590), is the first deuterium approved worldwide for the research of Huntington's disease, or other hyperkinetic movement disorders[1].体外研究(In Vitro):氢、碳和其他元素的稳定重同位素已被纳入药物分子中,主要作为药物开发过程中定量的示踪剂。氘化引起了人们的关注,因为它可能影响药物的药代动力学和代谢谱[1]。氘代化合物的潜在优势:(1)延长体内半衰期。氘代化合物或能够延长化合物的药代动力学特征,即延长体内半衰期。由此可提高化合物安全性、有效性和耐受性,并增加给药的便捷性。(2)提高口服生物利用度。氘代化合物或能够减少肠壁和肝脏中不需要的代谢 (首过代谢) 程度,使得更大比例的未代谢药物到达作用的目标位置。生物利用度高决定其在低剂量下具有活性以及更好的耐受性。(3)改善代谢特征。氘代化合物或能够减少有毒或反应性代谢物的形成,改善药物代谢状况。(4)改进药品安全性。氘代化合物或能够减少或消除药物化合物的不良副作用,具有安全性。(5)保留治疗特性。氘代化合物有望保留和此前研究中氢类似物相似的生化效力和选择性。德尔塔生物 has not independently confirmed the accuracy of these methods. They are for reference only.Clinical TrialNCT NumberSponsorConditionStart DatePhaseNCT04173260University of Pennsylvania|Teva Branded Pharmaceutical Products R&D, Inc.Dystonia, PrimaryAugust 6, 2020Phase 1|Phase 2NCT04071639Second Affiliated Hospital, School of Medicine, Zhejiang UniversityHuntington DiseaseMarch 12, 2020Phase 1NCT04301726Fundacion Huntington Puerto RicoHuntington DiseaseSeptember 1, 2020Phase 1 NCT04713982Vanderbilt University Medical Center|Teva Branded Pharmaceutical Products R&D, Inc.Huntington DiseaseNovember